The Hemoglobin Testing Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Hemoglobin Testing Market:
https://www.thebusinessresearchcompany.com/report/hemoglobin-testing-global-market-report
According to The Business Research Company’s Hemoglobin Testing Global Market Report 2024, The hemoglobin testing market size has grown strongly in recent years. It will grow from $2.54 billion in 2023 to $2.71 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to prevalence of anemia, maternal health initiatives, blood donation programs, chronic diseases management, global health awareness campaigns.
The hemoglobin testing market size is expected to see strong growth in the next few years. It will grow to $3.65 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to rising healthcare investments, integration with chronic disease management, point-of-care testing expansion, increasing focus on preventive healthcare, global health pandemics preparedness. Major trends in the forecast period include telemedicine and remote monitoring, technological advancements, home-based testing kits, integration with electronic health records (ehr), focus on non-invasive methods.
A rising prevalence of chronic disorders such as diabetes is expected to propel the growth of hemoglobin testing. Diabetes is a chronic condition that arises when the pancreas does not create enough insulin or when the body does not utilize the insulin that is produced adequately. Hemoglobin A1c tests (HbA1c) are used to monitor glucose levels in diabetic patients and are recommended by the American Diabetes Association as a viable option for fasting blood glucose for diabetes diagnosis. For instance, in November 2022, according to the US Census Bureau, a US-based department of the Federal Statistical System, more than 34 million Americans have diabetes, with an additional 88 million at risk. Additionally, in December 2021, according to the IDF Diabetes Atlas 10th edition published by the International Diabetes Federation, a Belgium-based global diabetes community, diabetes afflicted 536,000 individuals in 2021, and by 2030, it is predicted to climb to 642,800. By 2045, it will reach 783,700 individuals globally. Therefore, the rising prevalence of chronic disorders such as anemia and diabetes will drive the hemoglobin a1c testing devices market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=10059&type=smp
The hemoglobin testing market covered in this report is segmented –
1) By Product: Reagents And Consumables, Equipment
2) By Technology: Chromatography, Immunoassay, Spectrophotometry, Other Technologies
3) By End User: Hospitals, Clinics, Laboratories, Home Care Settings, Blood Banks, Other End Users
Major companies operating in the hemoglobin testing market are developing innovative products such as liquid chromatography analyzers to meet larger customer bases, more sales, and increase revenue. Liquid chromatography analyzers are analytical instruments designed for the separation, identification, and quantification of components in a liquid mixture. For instance, in June 2021, Trivitron Healthcare, an India-based medical technology company, launched NANO H5 and NANO H110, two high-performance liquid chromatography analyzers designed for the rapid detection of HbA1c in under 3 minutes. The distinctive feature of NANO H5, a compact and automated HPLC analyzer, lies in its utilization of ion exchange liquid chromatography for the rapid and quantitative determination of glycated hemoglobin (HbA1c) in human whole blood, boasting a swift processing time of 130 seconds that expedites laboratory turnaround time (TAT). On the other hand, NANO H110, another compact and automated HPLC analyzer, stands out with its dual test mode catering to both HbA1c testing and Hb variant detection. It incorporates advanced features such as a barcode scanner and cap piercing, coupled with a substantial sample loading capacity of 110 samples simultaneously, making it particularly well-suited for laboratories with medium to large workloads.
The hemoglobin testing market report table of contents includes:
1. Executive Summary
2. Hemoglobin Testing Market Characteristics
3. Hemoglobin Testing Market Trends And Strategies
4. Hemoglobin Testing Market - Macro Economic Scenario
5. Global Hemoglobin Testing Market Size and Growth
....................
31. Global Hemoglobin Testing Market Competitive Benchmarking
32. Global Hemoglobin Testing Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Hemoglobin Testing Market
34. Hemoglobin Testing Market Future Outlook and Potential Analysis
35. Appendix
Read Related Topics:
https://goodprnews.com/biocontrol-global-market-size/
https://goodprnews.com/biodegradable-paper-and-plastic-packaging-global-market-size/
https://goodprnews.com/benzoic-acid-global-market-size/
https://goodprnews.com/earth-and-space-mining-sensors-global-market-size/
https://goodprnews.com/egg-tray-global-market-share/
https://goodprnews.com/elastography-imaging-global-market-size/
https://topprnews.com/biocontrol-global-market-share/
https://topprnews.com/biodegradable-paper-and-plastic-packaging-global-market-share/
https://topprnews.com/benzoic-acid-global-market-2024-by-trends-key-drivers-top-manufacturers-opportunities-forecast-to-2033-emerald-kalama-llc-ig-petrochemicals-ltd-merck-kgaa/
https://topprnews.com/earth-and-space-mining-sensors-global-market-share/
https://topprnews.com/egg-tray-global-market-size/
https://topprnews.com/elastography-imaging-global-market-share/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
According to the recent report by IMARC Group, titled “Hemoglobin Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the market is currently witnessing strong growth.
A hemoglobin (Hgb) test determines the level of hemoglobin or the count of red blood cells (RBC) in the blood.
If the examination reveals low levels of hemoglobin than the standard range, then that means the body is prone to anemia and if it is higher, then it can be a symptom of other disorders.
Subsequently, the doctors prescribe medicines and dietary changes to maintain an optimum level of hemoglobin in the body.As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.Get a sample copy of this Report: https://www.imarcgroup.com/hemoglobin-testing-market/requestsampleGlobal Hemoglobin Testing Market Trends:Fast-paced lifestyles of the working population have led to irregular mealtime and increased the dependence on ready-to-eat food.
Improper diet and stress have led to a rise in the number of chronic diseases, like diabetes and anemia, thereby propelling the demand for hemoglobin testing.
Moreover, the provision of home care testing by several healthcare centers has made the test more convenient for users as they get doorstep services of collecting samples and faster results.
Hemoglobin testing is the process of carrying out diagnostic tests to detect the levels of hemoglobin in the patient’s blood.
Hemoglobin’s importance for providing essential nutrients and oxygen to the human body is immeasurable and hence the requirement for accurate monitoring and detection of hemoglobin levels is essential.
These tests generally do not require any special requests and can be carried out on the blood samples extracted from the patient.Market Analysis: Global Hemoglobin Testing MarketGlobal hemoglobin testing market is expected to register a substantial CAGR of 8.68% in the forecast period of 2019-2026.
The report contains data from the base year of 2018 and the historic year of 2017.
This rise in market value can be attributed to the accurate detection of various other diseases prevalent with low hemoglobin levels.Top Market Competitors:Few of the major competitors currently working in the global hemoglobin testing market are Abbott; Bio-Rad Laboratories, Inc.; Danaher; F. Hoffmann-La Roche Ltd; EKF Diagnostics; Siemens Healthcare GmbH; Thermo Fisher Scientific Inc.; ACON Laboratories, Inc.; Biomedomics Inc; Hemosure, Inc.; HUMASIS.COM; Immunostics Inc.; Germaine Laboratories, Inc.; Portea Medical; LifeSign LLC; Medixbiochemica; NanoEnTek Inc.; Quidel Corporation; Rtalabs; SA Scientific; TCS Biosciences Ltd.; Biohit Oyj; Microgen; Nova Biomedical and STRECK, INC. among others.Segmentation: Global Hemoglobin Testing MarketBy TechnologyChromatographyImmunoassayOthersBy End-UsersHospitalsResearch CentersLaboratoriesOthersBy Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)Market DriversIncreasing prevalence of diabetic population globally is expected to positively affect the growth of the marketRising prevalence of home-based diagnostic tests is expected to drive the growth of the marketAdvancements in technology resulting in rapid result detection is also expected to positively affect the growth of the marketMarket RestraintsHigh levels of costs associated with the medical devices and concerns regarding the high maintenance costs of these systems is expected to hinder its adoption rateAbsence of detection of other molecular components other than hemoglobin levels with this tests is expected to hinder the growth of the marketThe Detailed statistical analysis data is given or represented in Tabular format, Pie Charts, Graphs.
Get Free Sample Report Copy of hemoglobin testing Market @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-hemoglobin-testing-market Competitive Analysis:Global hemoglobin testing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.
Driving producers of restorative gadgets are expected to be enter in the worldwide rise of the glycated hemoglobin testing market.
Organizations specifically, Bio-Rad Laboratories, Bayer, Arkray, Chek Diagnostics, Diazyme Laboratories, X Lite-On Technology, TaiDoc Technology, Trinity Biotech, Siemens Healthcare, Ceragem Medisys, Tosoh Bioscience, DiaSys Diagnostic Systems, Erba Mannheim, Daiichi Biotech, Human Diagnostics, EKF Diagnostics, Mindray Medical, Sebia, and Randox Laboratories are relied upon to be seen as driving producers of gadgets utilized as a part of glycated hemoglobin tests.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=35429 As indicated in a report by Transparency Market Research (TMR), the worldwide market for glycated hemoglobin testing is anticipated to be somewhere worth US$ 705 mn before the year 2026.
The worldwide glycated hemoglobin testing market, North America is relied upon to command as far as worldwide revenue share.
Additionally, the utilization of these procedures will depend mainly upon the end-utilization of glycated hemoglobin tests.Request COVID Analysis on Glycated Hemoglobin Testing Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=35429 Point-of-care Segment to Dominate the Other Test Segments in the Global MarketPatients looking for glycated hemoglobin testing are developing more slant towards research center based tests.
While point-of-care glycated hemoglobin testing is comparatively more advantageous choice, the outcomes and symptomatic results of research facilities keep on spearheading their strength in the worldwide market.
The report additionally uncovers that healing facilities are likely to be the biggest end-clients of glycated hemoglobin testing in the worldwide market.
